Quinolines and Their Therapeutic Use
AssigneePulmagen Therapeutics (Asthma) Limited
InventorsJohn Gary Montana, Harry Finch, George Hynd, Michael Colin Cramp, Rosa Arienzo, Neville McLean
Life of this patent
Estimating the term…
Loading patent…
AssigneePulmagen Therapeutics (Asthma) Limited
InventorsJohn Gary Montana, Harry Finch, George Hynd, Michael Colin Cramp, Rosa Arienzo, Neville McLean
Estimating the term…
Compounds of formula (I) are CRTH2 ligands, useful in the treatment of, for example, asthma and COPD wherein: R1 is halogen or cyano; R2 is hydrogen or methyl; R3 and R4 are independently —OR6, C1-C6alkyl or C3-C6cycloalkyl, the latter two groups being optionally substituted by one or more halogen atoms; R5 is hydrogen or halogen; R6 is C1C6 alkyl or C3-C6 cycloalkyl, either of which being optionally substituted by one or more halogen atoms; X is —CH2—, —S—, or —O—; one of Y and Y1 is hydrogen and the other is OR6, —C(═O)R7, NR8SO2R6 or a heterocyclic group selected from those referred to in the specification; and R6, R7 and R8 are as defined in the specification.
A compound of formula (I) or a pharmaceutically acceptable salt thereof:
8-9. (canceled)
Dependencies are inferred from the claim text.